The Market..., page-171

All we need is a major investor buying on the Nasdaq, with a significant holding of IMMP.

Our invitation to the Biomarker conference on 7 Sep is a good sign of confidence in our Science.
I guess that might be the drive for the current accumulation activities on both markets.

https://www.biocentury.com/conferences/newsmakers-2018
NewsMakers presents a hand-picked group of public biotech companies whose corporate and regulatory milestones will drive stock prices. NewsMakers is recognized as the industry's key venue for companies to take their story to Wall Street each Fall. Thus, NewsMakers remains the best opportunity for business development executives and key members of the institutional investment and analyst communities to compare notes and assess the industry landscape.

Last year, more than 500 delegates congregated at NewsMakers, including money managers who controlled more than $600 billion in equity assets, with over $50 billion dedicated to healthcare and $15 billion dedicated to biotech.